Victory Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-9,318
Closed -$672K 2811
2020
Q4
$672K Buy
9,318
+498
+6% +$26.1K ﹤0.01% 1931
2020
Q3
$402K Buy
8,820
+334
+4% +$14K ﹤0.01% 2038
2020
Q2
$383K Sell
8,486
-6,858
-45% -$307K ﹤0.01% 2080
2020
Q1
$590K Buy
15,344
+5,940
+63% +$273K ﹤0.01% 2033
2019
Q4
$435K Buy
9,404
+544
+6% +$23.6K ﹤0.01% 2075
2019
Q3
$361K Buy
8,860
+7,901
+824% +$341K ﹤0.01% 2007
2019
Q2
$46K Sell
959
-1,671
-64% -$87.8K ﹤0.01% 1747
2019
Q1
$165K Buy
+2,630
New +$181K ﹤0.01% 1611
2018
Q1
Sell
-3,535
Closed -$106K 1985
2017
Q4
$106K Buy
3,535
+307
+10% +$8.89K ﹤0.01% 1686
2017
Q3
$107K Sell
3,228
-949
-23% -$32.9K ﹤0.01% 1690
2017
Q2
$140K Buy
4,177
+626
+18% +$18.7K ﹤0.01% 1610
2017
Q1
$103K Sell
3,551
-45
-1% -$1.11K ﹤0.01% 1637
2016
Q4
$80K Sell
3,596
-88
-2% -$1.72K ﹤0.01% 1629
2016
Q3
$68K Buy
+3,684
New +$69.5K ﹤0.01% 1658

Other funds holding BEAT

Victory Capital Management's BEAT Position: Q1 2021 in Review

Victory Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 9,318 shares — an estimated $672K sold.

Victory Capital Management first reported a position in BEAT in Q3 2016 and held it in 14 quarters. The position peaked at $672K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Victory Capital Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Victory Capital Management sold 9,318 BioTelemetry, Inc. shares in Q1 2021, an estimated $672K.
  • Victory Capital Management first reported a position in BioTelemetry, Inc. in Q3 2016 and held it in 14 quarters.
  • Victory Capital Management's BioTelemetry, Inc. position peaked at $672K in Q4 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Victory Capital Management's 13F filing for Q1 2021, filed 4 May 2021.